Clinical Trial Update: Irinotecan Liposome in Combination With Capecitabine [NA]

View source ↗

Summary

Clinical trial evaluating liposomal irinotecan in combination with capecitabine for pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Onivyde (irinotecan hydrochloride liposome injection)
• Xeloda (capecitabine)

Snippet

Sponsor: Junjie Hang | Conditions: Pancreatic Cancer | NA | Status: RECRUITING